How Al Attar reviews scientific sources
A teaching guide to how we select, label, link, and re-review the external research that supports Al Attar's herbal education.
دليل تعليمي لكيفية اختيار المصادر العلمية الخارجية ووسمها وربطها ومراجعتها.
By the end of this guide you should understand exactly how Al Attar Research handles a scientific source — from the moment a question is raised to the moment a reviewed article links out to a primary database.
بنهاية هذا الدليل ستفهم كيف يتعامل أبحاث العطار مع أي مصدر علمي — من السؤال إلى الرابط الخارجي.
Learning objectives
Before we start, here is what you should be able to do after reading this page.
Why source discipline matters
Herbal information online routinely mixes household tradition, product marketing, and scientific research. The result is confusion — and sometimes harm. Source discipline is the practice of keeping these layers visible and separate.
- A herb being studied is not the same as an Al Attar product being studied.
- A traditional use being widespread is not the same as a clinical effect being proven.
- A scientific link being available is not the same as a scientific claim being made.
The source review framework
Every source we link is judged against four layers. A source can be excellent in one layer and weak in another — we still link it, but we label it.
Identity
Who publishes it? Is it a primary literature index, a regulatory body, an open-access repository, or an educational summary?
Discipline
How does the source filter what appears in it? Indexing, peer review, regulatory authority, or editorial curation are not the same thing.
What it can prove
Each source has a ceiling. PubMed indexes; it does not validate. ClinicalTrials.gov registers; it does not conclude.
What it cannot prove
We state the ceiling out loud on every source card, so readers can interpret a result correctly.
Source review workflow
Every article on Al Attar Research goes through this exact pathway before it is published.
- 01Research question
- 02Database search (PubMed, PMC, Cochrane, ClinicalTrials.gov)
- 03Source screening and identity check
- 04Evidence level assignment
- 05Claims review (what can and cannot be said)
- 06Editorial review and bilingual edit
- 07Publication with outbound source links
- 08Literature watch — re-review at set intervals
Evidence hierarchy
Not every study carries the same weight. Where a source sits on this ladder changes how Al Attar describes it.
Key concepts
Glossary terms used throughout the site.
Primary literature
Original research reports as published by the authors.
Systematic review
A structured synthesis of multiple studies on a single question.
Preclinical study
Laboratory or animal research, not yet tested in humans.
Clinical trial
A planned human study testing an intervention under defined conditions.
Source transparency
Making the origin and ceiling of a source visible to the reader.
Claims discipline
Saying only what the evidence allows, and labelling what it does not.
Trusted external sources
The databases and reference bodies we link out to. Each card describes the source's identity, what it is useful for, and what it cannot prove.
PubMed
- What it is
- Free biomedical literature index maintained by the U.S. National Library of Medicine.
- Useful for
- Searching peer-reviewed biomedical abstracts and citations.
- Cannot prove
- A single indexed paper does not establish clinical effectiveness.
- Limitations
- Indexing is not a quality filter; many entries are abstracts only.
PubMed Central
- What it is
- Open-access full-text archive of biomedical and life sciences journal literature at NIH.
- Useful for
- Reading full-text open-access articles.
- Cannot prove
- Open-access availability is not a measure of study quality.
- Limitations
- Not every published paper is in PMC.
ClinicalTrials.gov
- What it is
- U.S. registry and results database of privately and publicly funded clinical studies worldwide.
- Useful for
- Seeing what trials are registered, ongoing, or completed.
- Cannot prove
- Registration does not equal a peer-reviewed published result.
- Limitations
- Coverage and quality vary by jurisdiction.
NCCIH
- What it is
- U.S. National Center for Complementary and Integrative Health — public health summaries.
- Useful for
- Plain-language balanced summaries on complementary topics.
- Cannot prove
- Plain-language summaries are not a substitute for primary literature.
- Limitations
- Summaries can lag behind the latest published research.
Google Scholar
- What it is
- Broad academic search across journals, books, theses, and citations.
- Useful for
- Citation tracking, finding related literature, locating preprints.
- Cannot prove
- Indexing on Scholar does not imply peer review or quality.
- Limitations
- Mixes peer-reviewed and grey literature without distinction.
Cochrane Library
- What it is
- Collection of systematic reviews and meta-analyses produced by Cochrane.
- Useful for
- Reading synthesised evidence on a clinical question.
- Cannot prove
- Absence of a Cochrane review does not mean a topic is unstudied.
- Limitations
- Many herbal topics have no Cochrane review yet.
EMA / HMPC
- What it is
- European Medicines Agency — Committee on Herbal Medicinal Products monographs.
- Useful for
- Regulatory framework for traditional and well-established herbal use in Europe.
- Cannot prove
- Monographs reflect regulatory frameworks, not absolute proof.
- Limitations
- Scope is regulatory, not clinical-outcome focused.
WHO Monographs
- What it is
- World Health Organization monographs on selected medicinal plants.
- Useful for
- Internationally recognised medicinal plant context.
- Cannot prove
- Monographs are not exhaustive efficacy proof.
- Limitations
- Not regularly updated for every herb.
NCBI Bookshelf
- What it is
- Free access to peer-reviewed books and chapters in life sciences and medicine.
- Useful for
- Long-form background reading on compounds, plants, and clinical topics.
- Cannot prove
- Textbook entries may not reflect the latest research.
- Limitations
- Update cadence varies by title.
MedlinePlus
- What it is
- Consumer health information service from the U.S. National Library of Medicine.
- Useful for
- Plain-language health topic pages, including herb and supplement entries.
- Cannot prove
- Consumer pages are summaries, not primary evidence.
- Limitations
- Less granular than primary literature.
EFSA
- What it is
- European Food Safety Authority — risk assessments on food, including botanicals.
- Useful for
- Botanical safety opinions and risk assessments.
- Cannot prove
- Risk assessments are not efficacy studies.
- Limitations
- Scope is safety / risk, not therapeutic.
FDA — Botanical Drug Development
- What it is
- U.S. FDA guidance and resources on botanical drug development.
- Useful for
- Understanding the U.S. regulatory pathway for botanical products.
- Cannot prove
- Regulatory guidance is not clinical proof.
- Limitations
- Scope is regulatory and U.S.-jurisdiction specific.
Applied example
A walk-through showing how a single herb is reviewed using the framework above.
Chamomile
- Herb identity
- Matricaria chamomilla / أزهار البابونج
- Traditional context
- Documented household evening herbal routine across the Levant and wider region.
- Research links
- Outbound search on PubMed, PMC, NCCIH, and Cochrane — never paraphrased on our side.
- Evidence level
- Mixed: traditional use is well documented; clinical evidence is still emerging.
- Safety note
- Allergy and cross-reactivity caution for users sensitive to Asteraceae plants.
- Al Attar connection
- Related chamomile herbal products live on the official al-attar.net product website.
- Claim boundary
- No diagnosis, treatment, or cure claim is made on any Al Attar surface.
How to interpret what you read
- Traditional use does not equal clinical proof.
- A study on a herb does not mean an Al Attar product has been clinically tested.
- External research links are for education and transparency — not endorsement.
- Product information should be checked through the official Al Attar website.
- Last-updated dates matter; evidence matures.
- We do not claim Al Attar products diagnose disease.لا ندّعي أن منتجات العطار تُشخّص الأمراض.
- We do not claim Al Attar products treat disease.لا ندّعي أن منتجات العطار تُعالج الأمراض.
- We do not claim external studies are studies on Al Attar products unless explicitly stated.لا ندّعي أن الدراسات الخارجية هي دراسات على منتجات العطار ما لم يُذكر ذلك صراحة.
- We do not invent clinical evidence, PMIDs, DOIs, or NCT IDs.لا نخترع أدلة سريرية أو معرّفات أبحاث.
- We do not present traditional use as clinical proof.لا نُقدّم الاستخدام التقليدي على أنه دليل سريري.
- We do not replace professional medical advice.لا نستبدل الاستشارة الطبية المهنية.
Limitations
- This page does not provide medical diagnosis or treatment guidance.
- It does not prove that any Al Attar product treats a disease.
- It does not replace professional medical advice.
- It does not claim every external study applies to every Al Attar product.
- It does not invent clinical evidence, PMIDs, DOIs, or trial IDs.
Key takeaways
- Sources are labelled by identity, discipline, and ceiling.
- A seven-step workflow runs from question to published article.
- Evidence sits on a ladder — we never inflate the rung.
- Traditional use and clinical evidence are always kept visibly separate.
- Al Attar product information lives only on the official al-attar.net website.
- Every linked source is opened in a new tab so the reader stays with the primary database.
Continue the learning pathway
Editorial policy
Read how articles are written, reviewed, and re-reviewed.
ContinueClaims policy
See exactly what is and is not claimed on Al Attar surfaces.
ContinueTraditional use vs evidence
A separate lecture comparing the two layers.
ContinueClinical trial search guide
Hands-on guide to searching ClinicalTrials.gov.
ContinueSafety disclaimer
How safety wording is built and where its limits sit.
ContinueOfficial products
Current Al Attar products live on the official site.
OpenFrequently asked
Do you write your own clinical trials?+
No. We do not run, fund, or invent clinical trials. We link out to public databases where readers can review the primary record themselves.
Why don't you summarise studies in detail?+
Summaries risk drift. We prefer to keep the reader in front of the primary source so the interpretation stays accountable.
Is a PubMed indexing the same as a peer review?+
No. Indexing is a discoverability layer; peer review is a quality process applied by the journal.
How often are pages reviewed?+
Every page carries a review status and a last-updated date. High-traffic and safety-sensitive pages are re-checked more frequently.
Where can I buy Al Attar products?+
On the official al-attar.net website. Product information is never published on this research site.
This research site is the educational and source-transparency layer for Al Attar. For current products, packaging, and availability, continue to the official Al Attar product website.
Visit the official al-attar.netContinue to the official Al Attar product website
Current product details, categories, packaging, and availability live on the official Al Attar product website. This page is educational — never commercial.
تفاصيل المنتجات الحالية، الفئات، التغليف، والتوفر متاحة على الموقع الرسمي لمنتجات العطار.